News about Global Pharma

MedPharm Announces Merger with Tergus Pharma

MedPharm, Ltd. has announced a merger with Tergus Pharma, a Great Point Partners portfolio company.

Global Pharma | 10/07/2024 | By Aishwarya |  782

TuHURA Biosciences Signs Exclusivity and Right of First Offer Deal for Kineta

TuHURA Biosciences, Inc. has entered into an Exclusivity and Right of First Offer Agreement with Kineta, Inc. for the potential acquisition of Kineta's KVA12123 anti-VISTA antibody and related rights and assets associated with and derived from the asset.

Global Pharma | 09/07/2024 | By Aishwarya |  687

CASI Pharmaceuticals Appoints Daniel Lang as New CFO and SVP

CASI Pharmaceuticals, Inc. has appointed Daniel Lang, MD as Chief Financial Officer and Senior Vice President.

Global Pharma | 09/07/2024 | By Aishwarya |  1029

Lilly to Acquire Morphic to Enhance Outcomes for Patients with IBD

Eli Lilly and Company has signed a definitive agreement to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases.

Global Pharma | 09/07/2024 | By Aishwarya |  846

Myricx Bio Secures EUR 90 Million in Series A Financing

Myricx Bio has raised EUR 90 Million (USD 114 Million) in the latest Series A financing round.

Global Pharma | 08/07/2024 | By Aishwarya |  541

SmartCella Receives EUR 50 Million to Boost Commercialization of mRNA Operations

SmartCella Holding has announced a new share issue raising approximately EUR 50 million to accelerate growth and support commercialization of the Extroducer and the company's cell and mRNA operations.

Global Pharma | 08/07/2024 | By Aishwarya |  555

Ascentage Pharma Olverembatinib Gets Approval from ISAF for Commercialization in Macau China

Ascentage Pharma has announced that its BCR-ABL1 tyrosine kinase inhibitor (TKI), olverembatinib, has been approved by the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region (SAR) of the People's Republic of China.

Global Pharma | 08/07/2024 | By Aishwarya |  522

Innovent Signs Agreement with IASO Bio for Cell Therapy

Innovent Biologics, Inc. and IASO Biotechnology have signed an agreement on a series of cooperation, including IASO Bio's purchase from Innovent regarding its relevant right of FUCASO (Equecabtagene Autoleucel) and obtaining license from Innovent regarding the intellectual property related to FUCASO, as well as Innovent's equity investment in IASO Bio.

Global Pharma | 06/07/2024 | By Aishwarya |  836

Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets

Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).

Global Pharma | 06/07/2024 | By Aishwarya |  595

AbbVie Announces New Chief Executive Officer

AbbVie has announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors.

Global Pharma | 06/07/2024 | By Aishwarya |  1116